Abstract:Human milk oligosaccharides (HMO) are the third most significant solid component in human milk, working in conjunction with other bioactive components. Numerous factors, including secretor status, race, geography, climate, season, maternal nutrition and weight, gestational age, and delivery method, significantly affect the individual HMO levels and distribution among mothers. In addition to strengthening the epithelial barrier, producing immunomodulatory metabolites, and promoting a gut microbiota rich in Bifidobacterium, HMO also help to enhance the gastrointestinal barrier. HMO perform a range of physiological roles, such as possible immune system support, brain growth, and cognitive function. HMO supplementation to infant formula is safe and supports the newborn's healthy growth, with benefits for infection prevention and the makeup of the microbiota. Through a thorough and methodical evaluation of relevant literature, this study investigated the complex interactions between gut microbiota, the immune system, and HMO in neonates. A sizable corpus of recently released original research publications and thorough review papers were examined in the review. SCOPUS, PubMed, and Google Scholar were reliable and strong sources of information. In addition to these, a few more trustworthy sources were consulted. By reading this article, readers will have a clear understanding of how HMO play a crucial role in influencing the dynamics of the gut microbiota and supporting the development of the immune system in newborns. The knowledge gained from these exchanges may help direct measures meant to improve the health of newborns. However, further investigation is necessary to identify certain underlying processes and possible treatment paths. It is unknown if HMO provide an extra clinical advantage over non-human oligosaccharides due to a lack of research comparing the effects of the two. Better study of the variables controlling HMO composition and their functions will assist to comprehend their short- and long-term advantages for Immunity and Healthy Digestive System in Newborn Infants Throughout Life.

How Far is It from Infant Formula to Human Milk? A Look at the Human Milk Oligosaccharides

Human Milk Oligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula

Human milk oligosaccharides and infant gut microbiota: Molecular structures, utilization strategies and immune function

Human Milk Oligosaccharides: A Critical Review on Structure, Preparation, Their Potential As a Food Bioactive Component, and Future Perspectives.

Modifiable and Non-Modifiable Factors That Affect Human Milk Oligosaccharides Composition

Functional effects of human milk oligosaccharides (HMOs)

Oligosaccharides in human milk: structural, functional, and metabolic aspects

Human Milk Oligosaccharides Combine with Bifidobacterium Longum to Form the “golden Shield” of the Infant Intestine: Metabolic Strategies, Health Effects, and Mechanisms of Action

Gastrointestinal barrier function, immunity, and neurocognition: The role of human milk oligosaccharide (hMO) supplementation in infant formula

Gold standard for nutrition: a review of human milk oligosaccharide and its effects on infant gut microbiota

Human Milk Oligosaccharides: Potential Upshot on Health at Early Life Stage Development

Human Milk Oligosaccharides and Immune System Development

Research Progress on HMOs Interacting with Intestinal Flora to Regulate Infant Immune Function

The Science of Human Milk Oligosaccharides (HMO) for Developing Immunity and Healthy Digestive System in Newborn Infants Throughout Life

In Vitro Infant Fecal Fermentation Characteristics of Human Milk Oligosaccharides Were Controlled by Initial Microbiota Composition More Than Chemical Structure.

Current Advances in Structure–Function Relationships and Dose-Dependent Effects of Human Milk Oligosaccharides

Biology of human milk oligosaccharides: From basic science to clinical evidence

Insight into the Key Bridge for Infant’s Nutrition and Health: How to Explore Personalized Utilization Pathways from Diverse Human Milk Oligosaccharides

An In Vitro Colonic Fermentation Study of the Effects of Human Milk Oligosaccharides on Gut Microbiota and Short-Chain Fatty Acid Production in Infants Aged 0-6 Months

Human Milk Oligosaccharides and Lactose Differentially Affect Infant Gut Microbiota and Intestinal Barrier In Vitro

In Love with Shaping You-Influential Factors on the Breast Milk Content of Human Milk Oligosaccharides and Their Decisive Roles for Neonatal Development